Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world setting

BACKGROUND: In pivotal studies with direct-acting antivirals (DAAs), rates of sustained virological response in hepatitis C genotype 1 infection are >90%. OBJECTIVE: The objective of this article is to assess real-world safety and effectiveness of DAA treatment in a prospective multicenter regist...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:United European Gastroenterol J
Autori principali: Höner zu Siederdissen, Christoph, Buggisch, Peter, Böker, Klaus, Schott, Eckart, Klinker, Hartwig, Pathil, Anita, Pfeiffer-Vornkahl, Heike, Berg, Thomas, Sarrazin, Christoph, Hüppe, Dietrich, Manns, Michael P, Mauss, Stefan
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833224/
https://ncbi.nlm.nih.gov/pubmed/29511551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640617716607
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi